Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia

References

• Moulis G, Palmaro A, Montastruc J-L, et al. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124(22):3308–3315. doi:10.1182/blood-2014-05-578336.
   PubMed Web of Science ®Google Scholar
• JY LJ L, Lee H, Kang B, et al. Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea. Thromb Res. 2017;155:86–91. doi:10.1016/j.thromres.2017.05.010.
   PubMed Web of Science ®Google Scholar
• Gernsheimer T. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis. Oncologist. 2009;14(1):12–21. doi:10.1634/theoncologist.2008-0132.
   PubMed Web of Science ®Google Scholar
• Portielje JEWR, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97(9):2549–2554. doi:10.1182/blood.v97.9.2549.
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005;106(7):2244–2251. doi:10.1182/blood-2004-12-4598.
   PubMed Web of Science ®Google Scholar
• Elalfy MS, Nugent D. Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia. Semin Hematol. 2016;53(Suppl 1):S70–2. doi:10.1053/j.seminhematol.2016.04.021.
   PubMed Web of Science ®Google Scholar
• Chen YXY, Ruan M, Shi J. The levels of T lymphocyte subsets in immune thrombocytopenia associated with anti-GPIIb/IIIa- and/or anti-gpibα-mediated responses are differentially sensitive to dexamethasone. Acta Haematol. 2018;140(1):60–66. doi:10.1159/000491977.
   PubMed Web of Science ®Google Scholar
• XG MS L, Sun JZ, Ren J, et al. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia. Blood. 2011;117(6):2061–2069. doi:10.1182/blood-2010-07-295477.
   PubMed Web of Science ®Google Scholar
• Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008;8(5):337–348. doi:10.1038/nri2295.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo,VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27(1):485–517. doi:10.1146/annurev.immunol.021908.132710.
   PubMed Web of Science ®Google Scholar
• Aslam R, Hu Y, Gebremeskel S, et al. Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood. 2012;120(10):2127–2132. doi:10.1182/blood-2012-02-413526.
   PubMed Web of Science ®Google Scholar
• Li X, Zhong H, Bao W, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 2012;120(16):3318–3325. doi:10.1182/blood-2012-05-432575.
   PubMed Web of Science ®Google Scholar
• Olsson BAP, Jernås M, Jacobsson S, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9(9):1123–1124. doi:10.1038/nm921.
   PubMed Web of Science ®Google Scholar
• Nugent DMR, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol. 2009;146(6):585–596. doi:10.1111/j.1365-2141.2009.07717.x
   PubMed Web of Science ®Google Scholar
• Chow LAR, Speck ER, Kim M, et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood. 2010;115(6):1247–1253. doi:10.1182/blood-2009-09-244772.
   PubMed Web of Science ®Google Scholar
• Colantonio LRH, Sinigaglia F, D’Ambrosio D. Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells. Eur J Immunol. 2002;32(5):1264–1273. doi:10.1002/1521-4141(200205)32:5<264::aid-immu1264>3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma D, Zhu X, et al. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009;94(9):1326–1329. doi:10.3324/haematol.2009.007823.
   PubMed Web of Science ®Google Scholar
• Lyu M, Li Y, Hao Y, et al. CCR6 defines a subset of activated memory T cells of Th17 potential in immune thrombocytopenia. Clin Exp Immunol. 2019;195(3):345–357. doi:10.1111/cei.13233.
   PubMed Web of Science ®Google Scholar
• Paust HJRJ, Krebs CF, Turner JE. et al. CXCR3+ regulatory T cells control TH1 responses in crescentic GN. J Am Soc Nephrol. 2016;27(7):1933–1942. doi:10.1681/ASN.2015020203.
   PubMed Web of Science ®Google Scholar
• Ngwenyama N, Salvador AM, Velázquez F, et al. CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction. JCI Insight. 2019;4(7):e125527. doi:10.1172/jci.insight.125527.
   PubMed Web of Science ®Google Scholar
• Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol. 2015;27(1):11–20. doi:10.1093/intimm/dxu079.
   PubMed Web of Science ®Google Scholar
• Audia S, Samson M, Guy J, et al. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Blood. 2011;118(16):4394–4400. doi:10.1182/blood-2011-03-344051.
   PubMed Web of Science ®Google Scholar
• Olsson BRB, Carlsson L, Jacobsson S, et al. Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood. 2008;112(4):1078–1084. doi:10.1182/blood-2008-02-139402.
   PubMed Web of Science ®Google Scholar
• S WL L, Zhao C, Li L, et al. CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol. 2007;139(4):605–611. doi:10.1111/j.1365-2141.2007.06737.x.
   PubMed Web of Science ®Google Scholar
• Jiao Q, Liu C, Yang Z, et al. Upregulated PD-1 expression is associated with the development of systemic lupus erythematosus, but not the PD-1.1 allele of the PDCD1 gene. Int J Genomics. 2014;2014:950903. doi:10.1155/2014/950903
   PubMed Web of Science ®Google Scholar
• Reynolds J, Sando GS, Marsh OB, et al. Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis. Nephrol Dial Transplant. 2012;27(4):1343–1350. doi:10.1093/ndt/gfr529
   PubMed Web of Science ®Google Scholar
• Salama AD, Chitnis T, Imitola J, et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med. 2003;198(1):71–78. doi:10.1084/jem.20022119
   PubMed Web of Science ®Google Scholar
• Peled M, Strazza M, Azoulay-Alfaguter I, et al. Analysis of programmed death-1 in patients with psoriatic arthritis. Inflammation. 2015;38(4):1573–1579. doi:10.1007/s10753-015-0165-6
   PubMed Web of Science ®Google Scholar
• Kim JW, Lee J, Hong SM, et al. Circulating CCR7loPD-1hi Follicular Helper T cells indicate disease activity and glandular inflammation in patients with primary Sjögren’s syndrome. Immune Netw. 2019;19(4):e26. doi:10.4110/in.2019.19.e26.
   PubMed Web of Science ®Google Scholar
• Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16. doi:10.3390/jcm6020016.
   PubMed Web of Science ®Google Scholar
• Semple JW, Provan D. The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol. 2012;19(5):357–362. doi:10.1097/MOH.0b013e3283567541.
   PubMed Web of Science ®Google Scholar
• Alkebsi L, Kasamatsu T, Minato Y, et al. The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP. BMC Immunol. 2017;18(1):26. doi:10.1186/s12865-017-0210-3.
   PubMed Web of Science ®Google Scholar
• Ebbo M, Audonnet S, Grados A, et al. NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia. Clin Immunol. 2017;177:18–28. doi:10.1016/j.clim.2015.11.005.
   PubMed Web of Science ®Google Scholar
• Fang J, Lin L, Lin D, et al. The imbalance between regulatory memory B cells reveals possible pathogenesis involvement in pediatric immune thrombocytopenia. Hematology. 2019;24(1):473–479. doi:10.1080/16078454.2019.1622292.
   PubMed Web of Science ®Google Scholar
• Takahashi NST, Gotoh N, Nitta Y, et al. The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP. BMC Immunol. 2017;18(1):26. doi:10.1186/s12865-017-0210-3.
   PubMed Web of Science ®Google Scholar
• Rocha AMSC, Rocha GA, de Melo FF, et al. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica. 2011;96(10):1560–1564. doi:10.3324/haematol.2011.046417.
   PubMed Web of Science ®Google Scholar
• Xu R, Zheng Z, Ma Y, et al. Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia. Exp Ther Med. 2014;7(1):149–154. doi:10.3892/etm.2013.1386.
   PubMed Web of Science ®Google Scholar
• Wang JDCT, Lin HK, Huang FL, et al. Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2011;57(4):636–640. doi:10.1002/pbc.22984.
   PubMed Web of Science ®Google Scholar
• Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14(5):511–514. doi:10.1097/MOH.0b013e3282ba5552.
   PubMed Web of Science ®Google Scholar
• Chapman LMAA, Field DJ, Srivastava K, et al. Platelets present antigen in the context of MHC class I. J Immunol. 2012;189(2):916–923. doi:10.4049/jimmunol.
   PubMed Web of Science ®Google Scholar
• Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004;103(7):2645–2647. doi:10.1182/blood-2003-07-2268.
   PubMed Web of Science ®Google Scholar
• Munschauer FE, Hartrich LA, Stewart CC, et al. Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. J Neuroimmunol. 1995;62(2):177–181. doi:10.1016/0165-5728(95)00115-9.
   PubMed Web of Science ®Google Scholar
• La Cava A. Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev. 2008;8(1):83–87. doi:10.1016/j.autrev.2008.08.002.
   PubMed Web of Science ®Google Scholar
• Malinowska I, Obitko-Płudowska A, Buescher ES, et al. Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura. Hematol J. 2001;2(4):242–249. doi:10.1038/sj.thj.6200106.
   PubMedGoogle Scholar
• Yu J, Heck S, Patel V, et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood. 2008;112(4):1325–1328. doi:10.1182/blood-2008-01-135335.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang M, Zhou S, et al. Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia. J Transl Med. 2016;14(1):301. doi:10.1186/s12967-016-1064-9.
   PubMed Web of Science ®Google Scholar
• Birtas Atesoglu E, Tarkun P, Demirsoy ET, et al. Soluble Programmed Death 1 (PD-1) is decreased in patients with immune thrombocytopenia (ITP): potential involvement of PD-1 pathway in ITP immunopathogenesis. Clin Appl Thromb Hemost. 2016;22(3):248–251. doi:10.1177/1076029614562952.
   PubMed Web of Science ®Google Scholar
• Paulissen SM, van Hamburg JP, Dankers W, et al. The role and modulation of CCR25+ Th17 cell populations in rheumatoid arthritis. Cytokine. 2015;74(1):43–53. doi:10.1016/j.cyto.2015.02.002.
   PubMed Web of Science ®Google Scholar
• Zhong J, Chen S, Xu L, et al. Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP. Hematology. 2016;21(9):552‐557. doi:10.1080/10245332.2016.1155347.
   Web of Science ®Google Scholar
• Wan BNH, Liu A, Feng G, et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol. 2006;177(12):8844–8850. doi:10.4049/jimmunol.177.12.8844.
   PubMed Web of Science ®Google Scholar